Journal of Autoimmunity

Papers
(The TQCC of Journal of Autoimmunity is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats187
Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases166
Striatin-3 is a human autoantigen but it is not associated with the S-phase G2 nuclear antigen (SG2NA) staining pattern164
ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis137
HNF4α, SP1 and c-myc are master regulators of CNS autoimmunity128
Advances in SLE classification criteria125
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial117
Immunological and fibrotic profiling in the NOD.c3c4 murine model of autoimmune cholangitis111
Ectopic CD4+ T cells in choroid plexus mediate neuropsychiatric lupus symptoms in mice via interferon-γ induced microglia activation104
Autoreactivity to self-antigens LL37 and ADAMTSL5 influences the clinical response to risankizumab in psoriatic patients92
Differences in innate immune cell populations distinguish autoimmune from herpesvirus-associated encephalitis91
Breach of tolerance versus burden of bile acids: Resolving the conundrum in the immunopathogenesis and natural history of primary biliary cholangitis87
Editorial Board72
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations70
PAD2-mediated citrullination of MBP and early myelin destabilization in multiple sclerosis70
Global and regional epidemiology of psoriatic arthritis in patients with psoriasis: A comprehensive systematic analysis and modelling study69
Autoimmune associated HLAs and T cell autoantigens exhibit common patterns across several autoimmune diseases67
Tfh cell-derived small extracellular vesicles exacerbate the severity of collagen-induced arthritis by enhancing B-cell responses65
Lupus nephritis: new progress in diagnosis and treatment64
Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome63
Non-coding RNAs in immunoregulation and autoimmunity: Technological advances and critical limitations63
Editorial Board60
Editorial Board54
LAT1 enables T cell activation under inflammatory conditions54
Sunscreen use associated with elevated prevalence of anti-nuclear antibodies in U.S. adults53
Free water in the hippocampal cingulum as a Radiomic biomarker for Identifying inflammatory neuropsychiatric Lupus: A cross-sectional case-control study52
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow51
Editorial Board51
Mitochondrial dysfunction is a potential key mechanism for atherosclerosis predisposition in patients with systemic lupus erythematosus50
Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies48
Glycobiology of psoriasis: A review47
Antigenic mimicry – The key to autoimmunity in immune privileged organs42
Proinflammatory CD20+CD3+ T cells as a potential driver of macrophage reprogramming in rheumatoid arthritis42
Cellular communication network factor 3 contributes to the pathological process of rheumatoid arthritis through promoting cell senescence and osteoclastogenesis in the joint40
Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes40
Deciphering Sjögren's disease: New insights and perspectives extend from advanced omics approaches and immunology40
FAPI PET/CT for tracking disease trajectory in myositis-related interstitial lung disease39
Interferon signatures fuel B cell hyperactivity and plasmablast expansion in systemic lupus erythematosus39
Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation38
Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice36
Anti-annexin A4 antibody as a biomarker for desquamative interstitial pneumonia35
Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis35
The complement system and human autoimmune diseases34
External and internal exposome as triggers of biological signalling in systemic sclerosis – A narrative synthesis33
Editorial Board33
Antigen-specific immune reactions by expanded CD8+ T cell clones from HLA-B*27-positive patients with spondyloarthritis32
Autoimmune markers and vascular immune deposits in Finkelstein-Seidlmayer vasculitis: Systematic literature review31
Perinatal use of targeted synthetic DMARDs and maternal-neonatal outcomes in autoimmune disease: A population-based cohort study31
Renal and vascular outcomes in patients with isolated antiphospholipid syndrome nephropathy31
Single-cell sequencing of the retina shows that LDHA regulates pathogenesis of autoimmune uveitis31
Editorial Board30
Differential changes in the gut microbiota between extrinsic and intrinsic atopic dermatitis30
Long-term efficacy and safety of colchicine and anti-IL-1 blockers in FMF: results from the Eurofever multicenter observational study29
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach29
Familial patterns of alopecia areata: A systematic review and meta-analysis29
Peripheral immune profiling highlights a dynamic role of low-density granulocytes in myasthenia gravis29
Clinical utility of measuring CD4+ T follicular cells in patients with immune dysregulation29
Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus28
Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target28
Pregnancy-related complications in systemic lupus erythematosus27
The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis27
Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS proje27
Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice27
Silencing of aryl hydrocarbon receptor repressor restrains Th17 cell immunity in autoimmune hepatitis27
Coronavirus disease 2019, vaccination against coronavirus and immunoglobulin A-mediated diseases: systematic literature review27
The role of gut flora-driven Th cell responses in preclinical rheumatoid arthritis27
Altered lipid metabolism in synovial fibroblasts of individuals at risk of developing rheumatoid arthritis26
LAMP3-mediated epithelial-mesenchymal transition promotes the invasion and excessive proliferation of fibroblast-like synoviocytes in rheumatoid arthritis26
Functional metagenomic analysis reveals potential inflammatory triggers associated with genetic risk for autoimmune disease26
Autoantibodies against α-synuclein inhibit its aggregation and cytotoxicity26
T cell aging as a risk factor for autoimmunity26
Environmental exposures as risk factors for idiopathic inflammatory myopathies26
Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study26
Evaluation of the mycophenolate mofetil–rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)26
Editorial Board25
Temporal trajectories and DMARD therapy retention of rheumatoid arthritis patients with different autoimmune and inflammatory comorbidity profiles: a retrospective analysis25
Recent advances in cutaneous lupus25
Alternate splicing converts human CD137 from costimulatory to immunosuppressive function25
Interleukin 17-producing C-C motif chemokine receptor 6 + conventional CD4+ T cells are arthritogenic in an animal model of spondyloarthritis24
Extracellular vesicle autoantibodies24
Pathophysiological effects of long COVID-19 (auto)antibodies on fertility24
Identifying the genetic association between systemic lupus erythematosus and the risk of autoimmune liver diseases24
Significance of anti-transcobalamin receptor antibodies in cutaneous arteritis revealed by proteome-wide autoantibody screening24
Acquired susceptibility to autoimmune diseases in pediatric patients with Escherichia coli infection: A population-matched retrospective cohort study23
Anti-DNA antibody-targeted D-peptide nanoparticles ameliorate lupus nephritis in MRL/lpr mice23
Methotrexate and low-dose prednisone in idiopathic retroperitoneal fibrosis: a randomised clinical trial23
Gut microbiota in systemic lupus erythematosus: A fuse and a solution22
Exploration of new biomarkers for rheumatoid arthritis based on plasma proteomics and transcriptome integrated with genome-wide Mendelian randomization22
Interleukin-15 is a hair follicle immune privilege guardian22
Randomized controlled single-center clinical trial of high-intensity interval training in patients with systemic lupus erythematosus22
Pro-fibrotic effect of the susceptible gene PCSK5 in vascular fibrosis of Takayasu arteritis via TGF-β and SMAD3 signaling pathway activation22
High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome22
Preliminary safety and efficacy of relmacabtagene autoleucel (relma-cel) in adults with moderately to severely active systemic lupus erythematosus: a phase I dose-escalation study22
2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis21
Natural IgG protects against early dissemination of vesicular stomatitis virus21
Pin1 maintains the effector program of pathogenic Th17 cells in autoimmune neuroinflammation21
Genetic and pharmacological targeting of GSDMD ameliorates systemic inflammation in macrophage activation syndrome21
JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study21
T follicular helper cells in autoimmune diseases21
Physical work demands and risk of rheumatoid arthritis, systemic sclerosis, and systemic lupus erythematosus. A Danish longitudinal cohort study20
Comprehensive description of adult-onset Still's disease after COVID-19 vaccination20
VEXAS syndrome: A newly identified X-Linked hematoinflammatory disorder – A comprehensive overview of its genetic, molecular, inflammatory, and clinical landscape20
Multi-omics study reveals different pathogenesis of the generation of skin lesions in SLE and IDLE patients19
Editorial Board19
Application of laboratory models for sarcoidosis research19
Acute-type acquired hemophilia A after COVID-19 mRNA vaccine administration: A new disease entity?19
Fecal microbiota transplantation in the treatment of systemic lupus erythematosus: What we learnt from the explorative clinical trial19
CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus18
Autoimmune diseases and the risk of bladder cancer: A Mendelian randomization analysis18
Association between age groups and relapse of type 1 autoimmune pancreatitis: a large-scale retrospective cohort study18
Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells18
A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile18
Neonatal total parenteral nutrition and the risk of childhood autoimmune diseases: A nationwide population-based study of 2.3 million children18
Altered glucose metabolism in B cells: Implications for the pathogenesis and treatment of autoimmune diseases18
Immunosuppression induces regression of fibrosis in primary biliary cholangitis with moderate-to-severe interface hepatitis18
Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sjögren's syndrome: Novel biomarkers for disease activity and subsets17
PD1+ innate lymphoid cells 3 predict JAK-dependent inflammation in rheumatoid arthritis17
Vascular effects of achieving low disease activity in axial spondyloarthritis – A 2-year prospective treat-to-target study17
Poorer survival for patients with inflammatory arthritis treated with immune checkpoint inhibitors for melanoma17
Chimeric antigen receptor T cell therapy: a new frontier therapeutic landscape in autoimmune diseases17
Treatment of mixed connective tissue disease: A multicenter retrospective study17
Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases17
Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease16
PD-1 antibody interactions with Fc gamma receptors enable PD-1 agonism to inhibit T cell activation – therapeutic implications for autoimmunity16
Amelioration of immunoglobulin A vasculitis by suppression of the pathological expansion of T follicular helper 17 cells16
Outcome and prognosis of isolated carotid vasculitis16
Sonic hedgehog promotes synovial inflammation and articular damage through p38 mitogen-activated protein kinase signaling in experimental arthritis16
Regulatory T cells effectively downregulate the autoimmune anti-MPO response and ameliorate anti-MPO induced glomerulonephritis in mice16
Developmental drugs for sarcoidosis16
Autoimmune hepatitis following COVID-19 vaccination16
Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR database16
Repeated immunization with ATRA-containing liposomal adjuvant transdifferentiates Th17 cells to a Tr1-like phenotype16
Cognitive dysfunction in SLE: An understudied clinical manifestation16
The double-edged sword role of copper in rheumatoid arthritis: Mechanisms, therapeutics, and challenges16
Cytokine producing B-cells and their capability to polarize macrophages in giant cell arteritis16
Comparative effectiveness of preventive treatment with dimethyl fumarate-loaded solid lipid nanoparticles and oral dimethyl fumarate in a mouse model of multiple sclerosis16
Autophagy pathways in autoimmune diseases16
0.7238130569458